Deborah Armstrong
Director, Breast and Ovarian Surveillance Service · Johns Hopkins University School of Medicine
Credentials: · · · ·
History
- 1987–1989
Medical Oncology
- 1984–1987
Internal Medicine
1980–1984
Research
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Science · 2017 · 5,443 citations
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
New England Journal of Medicine · 2006 · First of 10 authors · 2,043 citations
Systematic review or meta-analysis · Journal of Clinical Oncology · 2002 · 1,842 citations
22 papers
20 papers
19 papers
- RC
19 papers
- JF
18 papers
17 papers
- AW
16 papers
16 papers
Grants
- 2019–2032
- 2014–2019
Johns Hopkins University NCTN Lead Academic Site Program
National Cancer Institute · U10
PI · $3.3M · Johns Hopkins University
- 2005–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $11.1K · Johns Hopkins University
- 1996–2001
Autologous Graft-vs-Host Disease in Human Breast Cancer
National Cancer Institute · R01
Contact PI · $182.1K · Johns Hopkins University
Clinical trials
- 2007–2008
Principal investigator · Terminated · Phase 2
Facet Biotech
- 2002
Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
- 2000
Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
Study chair · Completed · Phase 1
Gynecologic Oncology Group
- 1998
Study chair · Completed · Phase 3
Gynecologic Oncology Group